MedTrace Logo

Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy

NCT04874246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2023-06-26

No results posted yet for this study

Summary

The purpose of this study is to compare the effect of the concentration of vasopressin, which is used as a method for reducing blood loss in robot-assisted laparoscopic myomectomy.

Conditions

  • Uterine Leiomyoma

Interventions

DRUG

Vasopressin

During robot-assisted laparoscopic myomectomy, vasopressin diluted to different concentrations will be injected before uterine serosal incision.

Sponsors & Collaborators

  • CHA University

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hee Seung Kim, MD/PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-10
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04874246 on ClinicalTrials.gov